Target intelligence / Profile preview

Intestinal barrier and gut epithelial function

Molecular classification
Cell junction proteins [4], Transporters [1], Mucins [1], Cytokines [3], Growth factors [2]
01

Overview

The intestinal barrier and gut epithelial function represent a complex physiological system responsible for maintaining a selective interface between the external environment and the internal milieu. It consists of a physical barrier composed of mucus and epithelial cells, a chemical barrier of antimicrobial peptides, and an immunological barrier involving gut-associated lymphoid tissue [1][3]. The primary molecular components include tight junction proteins like claudins and occludin, which regulate paracellular transport and prevent the translocation of harmful substances [4]. Dysfunction of this barrier, often termed "leaky gut," is implicated in various systemic and gastrointestinal diseases, including inflammatory bowel disease and metabolic disorders [2][5]. Therapeutic strategies aim to reinforce this barrier through the use of growth factors, tight junction modulators, and anti-inflammatory agents to restore selective permeability and reduce systemic inflammation [2].

Other names
Intestinal epithelial barrierGut barrier functionMucosal barrierIntestinal permeability
02

Mechanism of action

Drugs targeting this system typically act by stimulating epithelial cell proliferation (e.g., GLP-2 analogs), modulating tight junction assembly (e.g., zonulin antagonists), or enhancing the protective mucus layer to restore selective permeability and reduce systemic inflammation [1][2][5].

03

Biological functions

Selective permeability [1]Immune homeostasis [3]Nutrient absorption [1]Pathogen exclusion [2]Epithelial cell turnover [4]
04

Disease associations

Inflammatory bowel disease [1]Celiac disease [5]Irritable bowel syndrome [5]Type 1 diabetes [2]Non-alcoholic fatty liver disease [2]
05

Safety considerations

Risk of mucosal hyperplasia with growth factors [2]Potential for promoting tumor growth in the presence of malignancy [2]Incomplete restoration of barrier function leading to chronic inflammation [1]
06

Interacting drugs

Teduglutide [2]

4 more in the full profile.

07

Biomarkers

Zonulin [1][5]Fecal calprotectin [1]Serum citrulline [5]Lactulose-to-mannitol ratio [5]Intestinal fatty acid-binding protein (I-FABP) [4]

Beyond the preview

Go deeper on Intestinal barrier and gut epithelial function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal barrier and gut epithelial function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call